Embryonic stem cells ameliorate piroxicam-induced colitis in IL10-/- KO mice.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2007-10-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BBRC.2007.07.139PMID 17692287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• REGIONAL ILEITISA PATHOLOGIC AND CLINICAL ENTITY

  2008cited by this paper
• A regulatory role of Wnt signaling pathway in the hematopoietic differentiation of murine embryonic stem cells.

  2004cited by this paper
• Validation of the interleukin‐10 knockout mouse model of colitis: antitumour necrosis factor‐antibodies suppress the progression of colitis

  2003cited by this paper
• Animal models of mucosal inflammation and their relation to human inflammatory bowel disease.

  1999cited by this paper
• Infliximab for the treatment of fistulas in patients with Crohn's disease.

  1999cited by this paper
• Defective NK cell activity and Th1 response in IL-18-deficient mice.

  1998cited by this paper
• Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice

  1998cited by this paper
• Cytokines in Inflammatory Bowel Disease

  1998cited by this paper
• IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.

  1998cited by this paper
• A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

  1997cited by this paper
• Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells.

  1997cited by this paper
• Studies with IL‐10‐/‐ mice: an overview

  1997cited by this paper
• Induction and prevention of colonic inflammation in IL-2-deficient mice.

  1997cited by this paper
• Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin‐12

  1997cited by this paper
• A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

  1997cited by this paper
• Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin‐10 or antibodies to interleukin‐12

  1996cited by this paper
• IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses

  1996cited by this paper
• IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses.

  1996cited by this paper
• Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells.

  1996cited by this paper
• Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system.

  1996cited by this paper
• Cloning of a new cytokine that induces IFN-γ production by T cells

  1995cited by this paper
• Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12

  1995cited by this paper
• Antibodies to interleukin 12 abrogate established experimental colitis in mice

  1995cited by this paper
• Cloning of a new cytokine that induces IFN-gamma production by T cells.

  1995cited by this paper
• Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

  1995cited by this paper
• Experimental models of inflammatory bowel disease.

  1995cited by this paper
• Gastrointestinal Inflammation: Inflammatory bowel disease in knockout mice

  1994cited by this paper
• B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation

  1994cited by this paper
• Interleukin‐12 regulates the proliferation of Th1, but not Th2 or Th0, clones

  1994cited by this paper
• Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1.

  1994cited by this paper
• Interleukin-10 and its receptor.

  1994cited by this paper
• Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

  1994cited by this paper
• Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

  1994cited by this paper
• Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

  1994cited by this paper
• Interleukin-10 and its receptor.

  1994cited by this paper
• Tumour necrosis factor alpha in stool as a marker of intestinal inflammation.

  1992cited by this paper
• Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10

  1992cited by this paper
• Cytokine secretion patterns and cross-regulation of T cell subsets

  1991cited by this paper
• Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection.

  1991cited by this paper
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

  1991cited by this paper
• Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.

  1990cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper

• Orally Bioavailable BRD4 BD1 Inhibitor ZL0516 Effectively Suppresses Colonic Inflammation in Animal Models of Inflammatory Bowel Disease.

  2025cites this paper
• Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges

  2023cites this paper
• The Impact of Cellular Therapies on Gastrointestinal Diseases: Applications and Challenges

  2023cites this paper
• Stem Cell-Based Therapies for Inflammatory Bowel Disease

  2022cites this paper
• Advances in stem cell therapy for intestinal diseases: mechanisms, perspectives regarding clinical applications, and challenges.

  2022cites this paper
• Quantitative analysis of neuronal mitochondrial movement reveals patterns resulting from neurotoxicity of rotenone and 6-hydroxydopamine

  2021cites this paper
• Potential of embryonic stem cells for treating intestinal diseases

  2021cites this paper
• [Features and management of very early onset inflammatory bowel disease].

  2018cites this paper
• Investigation of the Pathophysiology and In-Utero Treatment of Gastroschisis-Related Intestinal Dysfunction

  2018cites this paper
• A Paediatric Perspective on Stem Cells: Expression, Function, and Clinical Relevance (Stem Cells from Amniotic Fluid)

  2016cites this paper
• A Paediatric Perspective on Stem Cells: Expression, Function and Clinical Relevance

  2016cites this paper
• Animal models of ulcerative colitis and their application in drug research

  2013cites this paper
• Stem Cells Derived from Amniotic Fluid

  2013cites this paper
• Small Intestine Inflammation in Roquin-Mutant and Roquin-Deficient Mice

  2013cites this paper
• Animal models of ulcerative colitis and their application in drug research

  2013cites this paper
• Human β2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammation.

  2012cites this paper
• Inflammatory bowel disease: review and future view.

  2012cites this paper
• Stem Cells from Amniotic Fluid

  2011cites this paper
• Stem cells as potential therapeutic targets for inflammatory bowel disease.

  2010cites this paper
• Administration of human umbilical cord blood cells produces interleukin-10 (IL-10) in IL-10 deficient mice without immunosuppression.

  2010cites this paper
• Stem cells as a potential future treatment of pediatric intestinal disorders.

  2008cites this paper
• Stem cell‐based therapy in gastroenterology and hepatology

  2008cites this paper